Lidocaine HCL 1% 50 MG/5 ML VL 5ML
Ended Awarded
- Contract number
- SPE2DB25FRX52
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,376
Award facts
- Contract value 100% obligated
- $1,376.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.18 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 mL vials (5 mL quantity). The award is firm fixed price with no set-aside designation, reflecting a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which functions as a comprehensive global pharmaceutical support vehicle.
The underlying IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Through this contract vehicle, the company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for lidocaine represents a routine pharmaceutical procurement from the DLA's medical supply chain, with completion scheduled for August 11, 2025. The competitive award history and firm fixed pricing structure demonstrate AmerisourceBergen's established capability in fulfilling federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FRX52?
SPE2DB25FRX52 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FRX52 worth?
The government has obligated $1,376 on SPE2DB25FRX52.
Is contract SPE2DB25FRX52 an order under another contract?
Yes. SPE2DB25FRX52 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRX52 competed?
The extent of competition for SPE2DB25FRX52 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award